SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-242293
Filing Date
2020-09-09
Accepted
2020-09-09 17:26:12
Documents
15
Period of Report
2020-09-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d831321d8k.htm   iXBRL 8-K 25966
2 EX-99.1 d831321dex991.htm EX-99.1 9253
3 EX-99.2 d831321dex992.htm EX-99.2 19932
7 GRAPHIC g831321g15q88.jpg GRAPHIC 103464
  Complete submission text file 0001193125-20-242293.txt   328299

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA itci-20200909.xsd EX-101.SCH 3112
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20200909_lab.xml EX-101.LAB 17374
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20200909_pre.xml EX-101.PRE 10981
8 EXTRACTED XBRL INSTANCE DOCUMENT d831321d8k_htm.xml XML 3214
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36274 | Film No.: 201167213
SIC: 2834 Pharmaceutical Preparations